Suzanne Smith, PA
Medical · West Columbia, SCNPI 1760582621
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Axonics, Inc. accounts for 84.8% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $10,994 and has fallen 76.1% since, to $2,626 in 2025. Among medical clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 436 payments — averaging $90.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$33K
- Boston Scientific$2K
- Medtronic$979
- Sumitomo Pharma America, Inc.$705
- AbbVie$503
- Astellas Pharma US Inc$469
- plus $1K from 15 others
What the payments were for
- Consulting fees$17,41044%
- Travel & lodging$11,29729%
- Food & beverage$10,52227%
- Education$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 201 | $33,348 |
| Boston Scientific | 27 | $1,858 |
| Medtronic | 46 | $979 |
| Sumitomo Pharma America, Inc. | 31 | $705 |
| AbbVie | 27 | $503 |
| Astellas Pharma US Inc | 24 | $469 |
| Coloplast | 27 | $404 |
| Antares Pharma, Inc. | 11 | $183 |
| Urovant Sciences Inc | 11 | $168 |
| Valencia Technologies Corporation | 6 | $159 |
| Pfizer | 6 | $115 |
| Hologic Sales And Service, LLC | 3 | $84 |
| Millicent US Inc | 4 | $83 |
| Femselect Inc. | 1 | $76 |
| ABC Home Medical Supply, Inc. | 2 | $37 |
| Mission Pharmacal Company | 2 | $35 |
| Dentsply IH AB | 2 | $24 |
| Organon | 2 | $23 |
| Bluewind Medical | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Hollister Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$22,763
- Axonics r-SNM System$7,199
- INTERSTIM$100
How this compares
$39,304 in reported general payments places this provider in the 95th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 278 | $208,815 |
| MyrbetriqMirabegron | 276 | $174,880 |
| Mirabegron ErMirabegron | 52 | $24,626 |
| Estradiol | 404 | $24,517 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 187 | $17,499 |
| OsphenaOspemifene | 23 | $10,127 |
| PremarinEstrogens, Conjugated | 22 | $8,570 |
| ImvexxyEstradiol | 31 | $7,606 |
| IntrarosaPrasterone (Dhea) | 29 | $7,457 |
| Solifenacin Succinate | 56 | $4,402 |
| Methenamine Hippurate | 52 | $3,019 |
| Clobetasol Propionate | 76 | $2,964 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 112 | $1,180 |
| Terconazole | 28 | $779 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 35 | $750 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $705 | $208,815278 claims |
| Astellas Pharma US IncMyrbetriq | $469 | $174,880276 claims |
| PfizerPremarin | $115 | $8,57022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 384 medical providers in South Carolina.
Other medical in West Columbia
- Anna ScottWest Columbia$16K
- Michelle EvansWest Columbia$9K
- Morgan ArmstrongWest Columbia$6K
- Wilfredo VillarrubiaWest Columbia$5K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.